Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
Journal for Immunotherapy of Cancer|June 23, 2016
Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumabJanet Retseck, Robert VanderWeele, Hui-Min Lin, et al.Journal of Translational Medicine|February 23, 2017
Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumabYana G Najjar, Fei Ding, Yan Lin, et al.Oncoimmunology|March 28, 2017
Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefitAhmad A Tarhini, Yan Lin, Hui-Min Lin, et al.Melanoma Research|February 11, 2014
Serologic evidence of autoimmunity in E2696 and E1694 patients with high-risk melanoma treated with adjuvant interferon alfaAhmad A Tarhini, Donghoon Shin, Sandra J Lee, et al.Future Oncology (London, England)|March 12, 2021
Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold techniqueCarol Mansfield, Kelley Myers, Kathleen Klein, et al.Journal of Translational Medicine|July 6, 2018
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanomaJanet Retseck, Alexis Nasr, Yan Lin, et al.Therapeutic Advances in Medical Oncology|August 9, 2019
Neoadjuvant therapy of locally/regionally advanced melanomaArjun Khunger, Zachary S Buchwald, Michael Lowe, et al.Revue De Pneumologie Clinique|June 26, 2013
[Malignant pleural mesothelioma after radiation treatment for Hodgkin lymphoma]F Vandenbos, M Figueredo, M-C Dumon-Gubeno, et al.Oncogene|September 8, 2023
Translation of AI into oncology clinical practiceIssam El Naqa, Aleksandra Karolak, Yi Luo, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 24, 2012
Differing patterns of circulating regulatory T cells and myeloid-derived suppressor cells in metastatic melanoma patients receiving anti-CTLA4 antibody and interferon-α or TLR-9 agonist and GM-CSF with peptide vaccinationAhmad A Tarhini, Lisa H Butterfield, Yongli Shuai, et al.Pageof 18